320 related articles for article (PubMed ID: 33066023)
1. Roles of Nrf2 in Liver Diseases: Molecular, Pharmacological, and Epigenetic Aspects.
Galicia-Moreno M; Lucano-Landeros S; Monroy-Ramirez HC; Silva-Gomez J; Gutierrez-Cuevas J; Santos A; Armendariz-Borunda J
Antioxidants (Basel); 2020 Oct; 9(10):. PubMed ID: 33066023
[TBL] [Abstract][Full Text] [Related]
2. Role of Nrf2 in Pancreatic Cancer.
Cykowiak M; Krajka-Kuźniak V
Antioxidants (Basel); 2021 Dec; 11(1):. PubMed ID: 35052602
[TBL] [Abstract][Full Text] [Related]
3. Regulation of Keap1-Nrf2 signaling: The role of epigenetics.
Cheng D; Wu R; Guo Y; Kong AN
Curr Opin Toxicol; 2016 Dec; 1():134-138. PubMed ID: 29057383
[TBL] [Abstract][Full Text] [Related]
4. The Anti-Inflammatory and Anti-Oxidant Mechanisms of the Keap1/Nrf2/ARE Signaling Pathway in Chronic Diseases.
Tu W; Wang H; Li S; Liu Q; Sha H
Aging Dis; 2019 Jun; 10(3):637-651. PubMed ID: 31165007
[TBL] [Abstract][Full Text] [Related]
5. Epigenetic regulation of Keap1-Nrf2 signaling.
Guo Y; Yu S; Zhang C; Kong AN
Free Radic Biol Med; 2015 Nov; 88(Pt B):337-349. PubMed ID: 26117320
[TBL] [Abstract][Full Text] [Related]
6. The Nrf2 Pathway in Liver Diseases.
Zhou J; Zheng Q; Chen Z
Front Cell Dev Biol; 2022; 10():826204. PubMed ID: 35223849
[TBL] [Abstract][Full Text] [Related]
7. Nrf2: friend and foe in preventing cigarette smoking-dependent lung disease.
Müller T; Hengstermann A
Chem Res Toxicol; 2012 Sep; 25(9):1805-24. PubMed ID: 22686525
[TBL] [Abstract][Full Text] [Related]
8. Nrf2 activators attenuate the progression of nonalcoholic steatohepatitis-related fibrosis in a dietary rat model.
Shimozono R; Asaoka Y; Yoshizawa Y; Aoki T; Noda H; Yamada M; Kaino M; Mochizuki H
Mol Pharmacol; 2013 Jul; 84(1):62-70. PubMed ID: 23592516
[TBL] [Abstract][Full Text] [Related]
9. Relationship between oxidative stress and nuclear factor-erythroid-2-related factor 2 signaling in diabetic cardiomyopathy (Review).
Wu X; Huang L; Liu J
Exp Ther Med; 2021 Jul; 22(1):678. PubMed ID: 33986843
[TBL] [Abstract][Full Text] [Related]
10. The Keap1/Nrf2 Signaling Pathway in the Thyroid-2020 Update.
Thanas C; Ziros PG; Chartoumpekis DV; Renaud CO; Sykiotis GP
Antioxidants (Basel); 2020 Nov; 9(11):. PubMed ID: 33158045
[TBL] [Abstract][Full Text] [Related]
11. Ezetimibe, an NPC1L1 inhibitor, is a potent Nrf2 activator that protects mice from diet-induced nonalcoholic steatohepatitis.
Lee DH; Han DH; Nam KT; Park JS; Kim SH; Lee M; Kim G; Min BS; Cha BS; Lee YS; Sung SH; Jeong H; Ji HW; Lee MJ; Lee JS; Lee HY; Chun Y; Kim J; Komatsu M; Lee YH; Bae SH
Free Radic Biol Med; 2016 Oct; 99():520-532. PubMed ID: 27634173
[TBL] [Abstract][Full Text] [Related]
12. Mechanistic studies of the Nrf2-Keap1 signaling pathway.
Zhang DD
Drug Metab Rev; 2006; 38(4):769-89. PubMed ID: 17145701
[TBL] [Abstract][Full Text] [Related]
13. Epigenetic Therapeutics Targeting NRF2/KEAP1 Signaling in Cancer Oxidative Stress.
Zhang S; Duan S; Xie Z; Bao W; Xu B; Yang W; Zhou L
Front Pharmacol; 2022; 13():924817. PubMed ID: 35754474
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of miR-200a protects cardiomyocytes against hypoxia-induced apoptosis by modulating the kelch-like ECH-associated protein 1-nuclear factor erythroid 2-related factor 2 signaling axis.
Sun X; Zuo H; Liu C; Yang Y
Int J Mol Med; 2016 Oct; 38(4):1303-11. PubMed ID: 27573160
[TBL] [Abstract][Full Text] [Related]
15. The role of Nrf2 in oxidative stress-induced endothelial injuries.
Chen B; Lu Y; Chen Y; Cheng J
J Endocrinol; 2015 Jun; 225(3):R83-99. PubMed ID: 25918130
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-200a improves diabetic endothelial dysfunction by targeting KEAP1/NRF2.
Jiang Z; Wu J; Ma F; Jiang J; Xu L; Du L; Huang W; Wang Z; Jia Y; Lu L; Wu H
J Endocrinol; 2020 Apr; 245(1):129-140. PubMed ID: 32031966
[TBL] [Abstract][Full Text] [Related]
17. Nuclear factor (erythroid-derived 2)-like 2 (NRF2) drug discovery: Biochemical toolbox to develop NRF2 activators by reversible binding of Kelch-like ECH-associated protein 1 (KEAP1).
Bresciani A; Missineo A; Gallo M; Cerretani M; Fezzardi P; Tomei L; Cicero DO; Altamura S; Santoprete A; Ingenito R; Bianchi E; Pacifici R; Dominguez C; Munoz-Sanjuan I; Harper S; Toledo-Sherman L; Park LC
Arch Biochem Biophys; 2017 Oct; 631():31-41. PubMed ID: 28801166
[TBL] [Abstract][Full Text] [Related]
18. Keap1/Nrf2 Signaling: A New Player in Thyroid Pathophysiology and Thyroid Cancer.
Renaud CO; Ziros PG; Chartoumpekis DV; Bongiovanni M; Sykiotis GP
Front Endocrinol (Lausanne); 2019; 10():510. PubMed ID: 31428048
[TBL] [Abstract][Full Text] [Related]
19. The molecular mechanism of Nrf2-Keap1 signaling pathway in the antioxidant defense response induced by BaP in the scallop Chlamys farreri.
Wang H; Pan L; Xu R; Si L; Zhang X
Fish Shellfish Immunol; 2019 Sep; 92():489-499. PubMed ID: 31220575
[TBL] [Abstract][Full Text] [Related]
20. Isoflavone biochanin A, a novel nuclear factor erythroid 2-related factor 2 (Nrf2)-antioxidant response element activator, protects against oxidative damage in HepG2 cells.
Liang F; Cao W; Huang Y; Fang Y; Cheng Y; Pan S; Xu X
Biofactors; 2019 Jul; 45(4):563-574. PubMed ID: 31131946
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
